Aura Biosciences (AURA) Retained Earnings (2020 - 2026)
Aura Biosciences' (AURA) quarterly Retained Earnings came in at -$514.1 million in Q1 2026, down 27.98% YoY from -$713.8 million in Q1 2025, and down 7.01% on a QoQ basis from -$480.4 million in Q4 2025.
Aura Biosciences (AURA) Retained Earnings (2020 - 2026) Analysis & Trends
Aura Biosciences (AURA) has 7 years of Retained Earnings data on file, last reported at -$514.1 million in Q1 2026.
- Quarterly Retained Earnings fell 27.98% year-over-year to -$514.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$514.1 million (down 27.98% YoY) and the FY2025 annual result came in at -$480.4 million, down 28.38% from the prior year.
- Retained Earnings slipped to -$514.1 million in Q1 2026, from -$480.4 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $611.5 million in Q3 2025 to a low of -$514.1 million in Q1 2026.
- A 5-year average of $14.3 million and a median of -$147000.0 in 2022 frame the typical range for Retained Earnings.
- The widest YoY moves for Retained Earnings: up 323010.16% in 2023, down 180292.52% in 2023.
- Tracing AURA's Retained Earnings over 5 years: stood at $406.6 million in 2022, then grew by 26.09% to $512.6 million in 2023, then sank by 173.0% to -$374.2 million in 2024, then fell by 28.38% to -$480.4 million in 2025, then slipped by 7.01% to -$514.1 million in 2026.
- The last three Retained Earnings figures came in at -$514.1 million (Q1 2026), -$480.4 million (Q4 2025), and $611.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Aura Biosciences | 797.49 Mn | 729.65 Mn | - | 914.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 914.77 Mn |
| Mar 31, 2026 | -514.10 Mn |
| Dec 31, 2025 | -480.42 Mn |
| Sep 30, 2025 | 611.46 Mn |
| Jun 30, 2025 | 603.33 Mn |
| Mar 31, 2025 | -401.71 Mn |
| Dec 31, 2024 | -374.23 Mn |
| Sep 30, 2024 | -348.39 Mn |
| Jun 30, 2024 | -327.35 Mn |
| Mar 31, 2024 | -307.01 Mn |
| Dec 31, 2023 | 512.62 Mn |
| Sep 30, 2023 | -265.18 Mn |
| Jun 30, 2023 | 413.33 Mn |
| Mar 31, 2023 | 408.67 Mn |
| Dec 31, 2022 | 406.56 Mn |
| Sep 30, 2022 | -147,000.00 |
| Jun 30, 2022 | -128,000.00 |
| Mar 31, 2022 | 306.06 Mn |
| Dec 31, 2021 | -152.14 Mn |
| Sep 30, 2021 | -140.50 Mn |